Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Some Teenagers Recreated Martin Shkreli's Crazy-Expensive Drug For $20

Huffington Post Thursday, 1 December 2016
When Martin Shkreli, the former CEO of Turing Pharmaceuticals, hiked up the price of a life-saving medication, one group of high school students saw an opportunity to do good.

Eight teenagers from Sydney Grammar School in Australia have collaborated with scientists from the University of Sydney to reproduce the active...
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: Newsy Studio - < > Embed

News video: Teenagers Recreate $750 Martin Shkreli Drug for $2 a Dose

Teenagers Recreate $750 Martin Shkreli Drug for $2 a Dose 01:16

A group of Australian students say they recreated the active ingredient in life-saving drug Daraprim for a fraction of its U.S. price.

You Might Like


Recent related news

Ex-drug executive Martin Shkreli wins separate fraud trial

Martin Shkreli, the former drug company executive who drew public outcry when he raised the price of a life-saving drug by 5,000 percent, will be tried for...
Raw Story - USAlso reported by •Reuters

Other recent news in World

Marine LE PEN, New Orleans, Arkansas: Your Monday Evening BriefingFrench election: Emmanuel Macron 'to blow MARINE LE PEN out of the water' in second round
Timeline of ARKANSAS execution from AP reporterDaniel W. Drezner: Six different ways of looking at a DONALD TRUMP tweet
NEW ORLEANS removes first of four Confederate statuesVENEZUELA protesters try to keep momentum
Sean Hannity calls SEXUAL HARASSMENT accusation '100% false'Soldier Claims To Have Recorded A Triangle Shaped UFO in AFGHANISTAN
LONDON knifeman caught with ISIS booklet is locked upCANADA House gives London, England a taste of Tim Hortons

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+